Quick Takeaways: Why It Matters? Jaguar’s NADA submission is a meaningful de-risking step for Canalevia-CA1, because full FDA approval would likely expand its commercial credibility beyond conditional use and make it easier to gain adoption in veterinary onc...
Quick Takeaways Why It Matters? Jaguar is extending its rainforest‑derived GI platform from niche equine/calf use into the much larger companion‑dog market with Neonorm Dog, giving it an OTC, plant‑based gut‑health brand that can sit alongside its prescription Canalevi...
